We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+4.07%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.46B
AUM Growth
+$89.1M
Cap. Flow
+$45.2M
Cap. Flow %
3.1%
Top 10 Hldgs %
26.33%
Holding
124
New
5
Increased
48
Reduced
14
Closed
6

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$20.6M
2
HAS icon
Hasbro
HAS
+$16.8M
3
CVS icon
CVS Health
CVS
+$12.4M
4
VLO icon
Valero Energy
VLO
+$7.98M
5
DD icon
DuPont de Nemours
DD
+$7.88M

Top Sells

Rank Stock Value
1
FE icon
FirstEnergy
FE
+$28M
2
CAG icon
Conagra Brands
CAG
+$23.6M
3
XOM icon
ExxonMobil
XOM
+$16M
4
OKE icon
Oneok
OKE
+$3.73M
5
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$3.18M

Sector Composition

Rank Sector Weight
1 Energy 14.54%
2 Financials 14.43%
3 Technology 13.77%
4 Healthcare 13%
5 Consumer Staples 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.84T
$44.7M 3.07%
334,000
-12,100
-3% -$1.54M
JPM icon
2
JPMorgan Chase
JPM
$939B
$43.8M 3%
391,917
+10,630
+3% +$1.17M
MRK icon
3
Merck
MRK
$324B
$42.1M 2.88%
525,572
+15,301
+3% +$1.17M
LMT icon
4
Lockheed Martin
LMT
$134B
$39.9M 2.74%
109,800
-500
-0.5% -$167K
PFE icon
5
Pfizer
PFE
$140B
$38.3M 2.62%
931,599
+79,788
+9% +$3.17M
VZ icon
6
Verizon
VZ
$194B
$37.8M 2.59%
661,720
+19,820
+3% +$1.14M
EPD icon
7
Enterprise Products Partners
EPD
$83.8B
$36.9M 2.53%
1,276,600
-12,670
-1% -$365K
CSCO icon
8
Cisco
CSCO
$450B
$36.5M 2.5%
666,400
+21,500
+3% +$1.19M
MCD icon
9
McDonald's
MCD
$188B
$32.4M 2.22%
155,800
+5,100
+3% +$1.01M
PEP icon
10
PepsiCo
PEP
$186B
$31.9M 2.19%
243,600
+7,500
+3% +$961K
QCOM icon
11
Qualcomm
QCOM
$176B
$31.8M 2.18%
417,900
+1,000
+0.2% +$73.2K
COST icon
12
Costco
COST
$415B
$31.2M 2.14%
118,000
+200
+0.2% +$49.8K
DAL icon
13
Delta Air Lines
DAL
$55.9B
$30.7M 2.11%
541,500
+800
+0.1% +$44.8K
PM icon
14
Philip Morris
PM
$301B
$30.6M 2.09%
389,200
+65,400
+20% +$5.4M
BAC icon
15
Bank of America
BAC
$435B
$30.5M 2.09%
1,050,100
+31,600
+3% +$911K
LLY icon
16
Eli Lilly
LLY
$1.07T
$29.5M 2.02%
266,296
+43,400
+19% +$5.11M
MS icon
17
Morgan Stanley
MS
$337B
$29.4M 2.01%
670,700
+23,700
+4% +$1.06M
MMP
18
DELISTED
Magellan Midstream Partners, L.P.
MMP
$27.2M 1.87%
425,600
-5,050
-1% -$314K
JNJ icon
19
Johnson & Johnson
JNJ
$635B
$26.8M 1.84%
192,600
+1,100
+0.6% +$152K
CVS icon
20
CVS Health
CVS
$137B
$26.5M 1.82%
486,800
+229,800
+89% +$12.4M
PSX icon
21
Phillips 66
PSX
$82.9B
$26.4M 1.81%
282,760
+68,500
+32% +$6.15M
PAYX icon
22
Paychex
PAYX
$40.4B
$26.1M 1.79%
316,800
+8,300
+3% +$700K
AEP icon
23
American Electric Power
AEP
$73.7B
$25.6M 1.75%
290,800
+8,400
+3% +$724K
DLR icon
24
Digital Realty Trust
DLR
$73.7B
$25.4M 1.74%
215,300
+3,900
+2% +$464K
GIS icon
25
General Mills
GIS
$19.2B
$24.9M 1.71%
474,700
+16,700
+4% +$863K
1
2 3 4 5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q2 2019 Portfolio in Review

As of Q2 2019, Payden & Rygel held 124 positions worth $1.46B, up 6.5% from $1.37B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Payden & Rygel deployed $45.2M of net new capital in Q2 2019, opening 5 new positions and adding to 48 existing holdings. Its largest new stake was Goldman Sachs: 104,100 shares worth $21.3M.

By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was ExxonMobil, an estimated $16M trimmed.

  • Payden & Rygel's largest Q2 2019 buy was Goldman Sachs: 104,100 shares worth $21.3M.
  • Payden & Rygel added most to CVS Health in Q2 2019, an estimated $12.4M increase.
  • Payden & Rygel's biggest Q2 2019 reduction was ExxonMobil, cutting an estimated $16M.
  • Payden & Rygel fully exited FirstEnergy in Q2 2019, selling an estimated $28M.
  • Payden & Rygel's ten largest holdings make up 26% of its $1.46B portfolio in Q2 2019.
  • Payden & Rygel opened 5 new positions and closed 6 in Q2 2019.
  • Payden & Rygel's portfolio value rose 6.5% quarter-over-quarter to $1.46B.

Based on Payden & Rygel's 13F filing for Q2 2019, filed 6 Aug 2019.